Fresenius Kabi USA LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fresenius Kabi USA LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3454
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable and specialty pharmaceutical products, transfusion technologies, parenteral nutrition and enteral nutrition. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Fresenius Kabi USA LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Licensing Agreements 13
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 13
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 14
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 15
Fresenius Kabi USA LLC – Key Competitors 16
Fresenius Kabi USA LLC – Key Employees 17
Fresenius Kabi USA LLC – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Nov 21, 2017: Fresenius Kabi to Expand Pharmaceutical Manufacturing in North Carolina 19
Sep 21, 2017: Fresenius Kabi breaks ground for $250 million manufacturing campus in Chicago 21
Legal and Regulatory 22
Apr 13, 2017: Fresenius Kabi Files Amicus Brief in Arkansas 22
Government and Public Interest 23
Dec 04, 2017: Fresenius Kabi Provides an Educational Grant for Continuing Education Session at ASHP Midyear Clinical Meeting & Exhibition 23
Nov 17, 2017: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kabi USA LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 11
APP Pharma Acquires Three Critical Care Products From Nexus Pharma 12
Medicines Company Enters Into Licensing Agreement With APP For Acute Care Generic Products 13
Caplin Point Laboratories Enters into Licensing and Distribution Agreement with Fresenius Kabi USA 14
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 15
Fresenius Kabi USA LLC, Key Competitors 16
Fresenius Kabi USA LLC, Key Employees 17
Fresenius Kabi USA LLC, Other Locations 18
Fresenius Kabi USA LLC, Subsidiaries 18

List of Figures
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kabi USA LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fresenius Kabi USA LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corum Group Ltd (COO):企業の財務・戦略的SWOT分析
    Summary Corum Group Ltd (Corum Group), is a technology company that owns businesses in technology and software development. The company offers point-of-sale and pharmaceutical dispensing software, support services and computer hardware. It provides products through corum health services and corum e- …
  • Sino Biopharmaceutical Ltd (1177):企業の財務・戦略的SWOT分析
    Sino Biopharmaceutical Ltd (1177) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • HeidelbergCement AG:企業のM&A・事業提携・投資動向
    HeidelbergCement AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HeidelbergCement AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Imaging Dynamics Company Ltd (IDL)-医療機器分野:企業M&A・提携分析
    Summary Imaging Dynamics Company Ltd (IDC) is a medical technology company that offers solutions in medical imaging and digital radiography technology. The company provides flat panel technology, CCD technology, 2200 X-series, 1600 Plus X-series, 1600 X-series, 1590 X-series, image processing softwa …
  • Powszechny Zaklad Ubezpieczen Group:戦略・SWOT・企業財務分析
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Westpac Banking Corporation:企業のM&A・事業提携・投資動向
    Westpac Banking Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westpac Banking Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Carnival Corporation & Plc (CCL):企業の財務・戦略的SWOT分析
    Carnival Corporation & Plc (CCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Nine Entertainment Co. Holdings Ltd:企業の戦略・SWOT・財務分析
    Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Exxon Mobil Corp (XOM):石油・ガス:M&Aディール及び事業提携情報
    Summary Exxon Mobil Corp (ExxonMobil) is an integrated oil and gas company that explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. It is a major manufacturer and …
  • Shermco Industries Inc:企業の戦略的SWOT分析
    Shermco Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ZAP (ZAAP):企業の財務・戦略的SWOT分析
    ZAP (ZAAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potent …
  • Powerflute Oy:企業の戦略的SWOT分析
    Powerflute Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • POP Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary POP Biotechnologies Inc (POP Biotechnologies) is a biotechnology company that develops and harnesses nano-scale technologies. The company’s product portfolio comprises of NP-01, an encapsulated nanoparticle used to impart systemic drug release; and C36 product, a cobalt indulged nanoparticle …
  • Uppsala University:企業のM&A・事業提携・投資動向
    Uppsala University - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uppsala University Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Shangri-La Asia Ltd:企業の戦略・SWOT・財務情報
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • QuickLogic Corporation (QUIK):企業の財務・戦略的SWOT分析
    QuickLogic Corporation (QUIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Westpac Banking Corporation:企業の戦略・SWOT・財務情報
    Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Graftys SA-医療機器分野:企業M&A・提携分析
    Summary Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆